Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of July 12 to 16, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of July 12 to 16, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
FDA to Prioritize Full Approval for Pfizer COVID-19 Vaccine
FRIDAY, July 16, 2021 (HealthDay News) — Pfizer Inc. announced on Friday that the U.S. Food and Drug Administration has granted priority review to its COVID-19 vaccine, positioning the vaccine for full approval by January.
Canada May Open Borders to Fully Vaccinated Americans by Mid-August
FRIDAY, July 16, 2021 (HealthDay News) — Fully vaccinated Americans may be able to visit Canada by mid-August, and fully vaccinated travelers from all countries may be able to visit by early September, Prime Minister Justin Trudeau said Thursday.
CDC Advisers to Discuss Third COVID-19 Vaccine Dose for Immunocompromised
FRIDAY, July 16, 2021 (HealthDay News) — Giving a third dose of COVID-19 vaccines to immunocompromised adults will be up for discussion during a U.S. Centers for Disease Control and Prevention advisory panel meeting next week.
U.S. Surgeon General Issues Call to Counter ‘Urgent Threat’ of Vaccine Misinformation
FRIDAY, July 16, 2021 (HealthDay News) — U.S. Surgeon General Vivek Murthy, M.D., on Thursday called on tech companies, health care workers, journalists, and ordinary Americans to do more to fight vaccine misinformation.
Staff Size, COVID-19 Outcomes Linked at Skilled Nursing Facilities
FRIDAY, July 16, 2021 (HealthDay News) — At skilled nursing facilities (SNFs), staff size, including staff members not involved in resident care, is strongly associated with COVID-19 outcomes, according to a study published online July 14 in Health Affairs.
Neutralizing Monoclonal Antibody Combo Treats Mild, Moderate COVID-19
FRIDAY, July 16, 2021 (HealthDay News) — For ambulatory patients with mild or moderate COVID-19 who are at high risk for progression to severe disease, bamlanivimab plus etesevimab infusion leads to a lower incidence of COVID-19-related hospitalization and death, according to a study published online July 14 in the New England Journal of Medicine.
Almost Half of Patients Admitted With COVID-19 Have Complications
FRIDAY, July 16, 2021 (HealthDay News) — Almost 50 percent of patients admitted to the hospital for management of COVID-19 have at least one complication, according to a study published online July 15 in The Lancet.
Restrictive Eating Disorders Up Among Teens During Pandemic
FRIDAY, July 16, 2021 (HealthDay News) — During the COVID-19 pandemic, there was a significant increase in medical admissions related to restrictive eating disorders among adolescents, according to a study published online July 8 in Pediatrics.
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths 
